PAR DRUGS AND CHEMICALS Financial Statement Analysis
|
||
|
The Revenues of PAR DRUGS AND CHEMICALS have increased by 27.54% YoY .
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has increased by 22.96 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
PAR DRUGS AND CHEMICALS Last 5 Annual Financial Results
[NSE : PAR]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹96 Cr | ₹75 Cr | ₹61 Cr | ₹56 Cr | ₹46 Cr |
| Expenses | ₹78 Cr | ₹59 Cr | ₹45 Cr | ₹46 Cr | ₹38 Cr |
| Operating Profit (Excl OI) | ₹18 Cr | ₹16 Cr | ₹16 Cr | ₹9.44 Cr | ₹8.20 Cr |
| Other Income | ₹0.24 Cr | ₹0.18 Cr | ₹0.19 Cr | ₹0.10 Cr | ₹0.09 Cr |
| Interest | ₹0.13 Cr | ₹0.45 Cr | ₹0.64 Cr | ₹0.79 Cr | ₹1.96 Cr |
| Depreciation | ₹3.23 Cr | ₹3.28 Cr | ₹2.82 Cr | ₹2.76 Cr | ₹3.04 Cr |
| Profit Before Tax | ₹15 Cr | ₹13 Cr | ₹15 Cr | ₹5.99 Cr | ₹3.29 Cr |
| Profit After Tax | ₹11 Cr | ₹9.21 Cr | ₹12 Cr | ₹4.77 Cr | ₹2.51 Cr |
| Consolidated Net Profit | ₹11 Cr | ₹9.21 Cr | ₹12 Cr | ₹4.77 Cr | ₹2.51 Cr |
| Earnings Per Share (Rs) | ₹9.21 | ₹7.49 | ₹18.87 | ₹7.75 | ₹5.60 |
| PAT Margin (%) | 10.46 | 10.86 | 16.81 | 7.50 | 4.74 |
| ROE(%) | 17.29 | 16.44 | 25.02 | 13.68 | 11.35 |
| ROCE(%) | 23.20 | 21.85 | 28.68 | 15.56 | 12.41 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.16 | 0.15 | 0.40 |
Key Financials |
||
| Market Cap | : | ₹ 347.7 Cr |
| Revenue (TTM) | : | ₹ 97.3 Cr |
| Net Profit(TTM) | : | ₹ 14.2 Cr |
| EPS (TTM) | : | ₹ 11.6 |
| P/E (TTM) | : | 24.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| PAR DRUGS AND CHEMICALS | 3.8% | 0.1% | 54.3% |
| PIDILITE INDUSTRIES | 4% | 9.7% | 25.7% |
| SOLAR INDUSTRIES INDIA | 7.9% | 35.1% | 139.9% |
| SRF | 6.1% | 8.2% | 8.6% |
| GUJARAT FLUOROCHEMICALS | -0.8% | -13% | 0.9% |
| DEEPAK NITRITE | 1.2% | -7.2% | 20.3% |
| TATA CHEMICALS | -3.1% | 11.2% | 9.8% |
| GODREJ INDUSTRIES | 2.6% | -5.7% | 83.1% |
| AARTI INDUSTRIES | 3.2% | -2.6% | 25.8% |
PAR DRUGS AND CHEMICALS Revenues
[NSE : PAR]
| Y-o-Y | 27.54 % |
| 5 Yr CAGR | 19.90 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹96 Cr | 27.54 | |
| Mar2022 | ₹75 Cr | 23.58 | |
| Mar2021 | ₹61 Cr | 8.78 | |
| Mar2020 | ₹56 Cr | 20.56 | |
| Mar2019 | ₹46 Cr | - | |
PAR DRUGS AND CHEMICALS Operating Profit
[NSE : PAR]
| Y-o-Y | 12.01 % |
| 5 Yr CAGR | 22.06 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹18 Cr | 12.01 | |
| Mar2022 | ₹16 Cr | 1.51 | |
| Mar2021 | ₹16 Cr | 69.58 | |
| Mar2020 | ₹9.44 Cr | 15.12 | |
| Mar2019 | ₹8.20 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -12.15 % |
| 5 Yr CAGR | 1.80 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 19.02% | -12.15 | |
| Mar2022 | 21.65% | -17.87 | |
| Mar2021 | 26.36% | 55.88 | |
| Mar2020 | 16.91% | -4.52 | |
| Mar2019 | 17.71% | - | |
PAR DRUGS AND CHEMICALS Profit After Tax
[NSE : PAR]
| Y-o-Y | 23.02 % |
| 5 Yr CAGR | 45.76 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹11 Cr | 23.02 | |
| Mar2022 | ₹9.21 Cr | -20.65 | |
| Mar2021 | ₹12 Cr | 143.67 | |
| Mar2020 | ₹4.77 Cr | 89.77 | |
| Mar2019 | ₹2.51 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -3.68 % |
| 5 Yr CAGR | 21.88 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 10.46 % | -3.68 | |
| Mar2022 | 10.86 % | -35.40 | |
| Mar2021 | 16.81 % | 124.13 | |
| Mar2020 | 7.5 % | 58.23 | |
| Mar2019 | 4.74 % | - | |
PAR DRUGS AND CHEMICALS Earnings Per Share (EPS)
[NSE : PAR]
| Y-o-Y | 22.96 % |
| 5 Yr CAGR | 13.24 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹9.21 | 22.96 | |
| Mar2022 | ₹7.49 | -60.31 | |
| Mar2021 | ₹19 | 143.48 | |
| Mar2020 | ₹7.75 | 38.39 | |
| Mar2019 | ₹5.60 | - | |
PAR DRUGS AND CHEMICALS Return on Capital Employed (ROCE)
[NSE : PAR]
| Y-o-Y | 6.18 % |
| 5 Yr CAGR | 16.93 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 23.2% | 6.18 | |
| Mar2022 | 21.85% | -23.81 | |
| Mar2021 | 28.68% | 84.32 | |
| Mar2020 | 15.56% | 25.38 | |
| Mar2019 | 12.41% | - | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Current Share Price | : | ₹282.7 |
| Current MarketCap | : | ₹ 347.7 Cr |
| Updated EOD on | : | Apr 16,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | 3.8% |
0.1% |
54.3% |
| SENSEX | -2.4% |
-1% |
21.3% |
PAR DRUGS AND CHEMICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about PAR DRUGS AND CHEMICALS Financials
How the annual revenues of PAR DRUGS AND CHEMICALS have changed ?
The Revenues of PAR DRUGS AND CHEMICALS have increased by 27.54% YoY .
How the Earnings per Share (EPS) of PAR DRUGS AND CHEMICALS have changed?
The Earnings Per Share (EPS) of PAR DRUGS AND CHEMICALS has increased by 22.96 % YoY .
Check out Intrinsic Value of Peers of PAR DRUGS AND CHEMICALS
Compare Stock Analytics of Peers of PAR DRUGS AND CHEMICALS
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs
PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs
